VECTIVBIO HLDG AG's ticker is VECT and the CUSIP is H9060V101. A total of 18 filers reported holding VECTIVBIO HLDG AG in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $30,725,023 | +6.2% | 3,610,461 | +8.1% | 2.03% | +12.2% |
| Q4 2022 | $28,919,931 | +44.3% | 3,339,484 | 0.0% | 1.81% | +89.1% |
| Q3 2022 | $20,037,000 | +11.1% | 3,339,484 | 0.0% | 0.96% | +7.5% |
| Q2 2022 | $18,033,000 | +13.3% | 3,339,484 | -1.2% | 0.89% | +5.7% |
| Q1 2022 | $15,922,000 | -7.9% | 3,380,402 | -4.0% | 0.84% | +2.6% |
| Q4 2021 | $17,293,000 | -36.4% | 3,522,019 | 0.0% | 0.82% | -41.7% |
| Q3 2021 | $27,190,000 | -33.8% | 3,522,019 | 0.0% | 1.41% | -22.8% |
| Q2 2021 | $41,067,000 | – | 3,522,019 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,592,602 | $20,028,000 | 5.85% |
| Novo Holdings A/S | 3,522,019 | $27,190,000 | 1.41% |
| Cormorant Asset Management, LP | 2,226,128 | $17,197,000 | 0.70% |
| NEA Management Company, LLC | 67,069 | $51,811,000 | 0.62% |
| Bpifrance SA | 2,806,217 | $21,678,000 | 0.50% |
| Orbimed Advisors | 5,123,304 | $39,578,000 | 0.44% |
| Eventide Asset Management | 2,339,044 | $17,599,000 | 0.23% |
| Tekla Capital Management LLC | 756,502 | $5,372,000 | 0.17% |
| Pinz Capital Management, LP | 48,073 | $371,000 | 0.17% |
| PFM Health Sciences, LP | 544,706 | $4,208,000 | 0.12% |